Interleukin 9 (IL9) is involved in mast cell maturation and the enhancement of IgE production by B cells. Furthermore, linkage data in human and mice have suggested that IL9 may contribute to asthma. Since our genetic analysis of the 5q cytokine cluster did not support a genetic role for the IL9 gene, we became interested in the IL9 receptor gene (IL9R) in the pseudoautosomal region. We genotyped markers sDF2 and sDF1 close to the IL9R gene among 289 affected and 368 family-based controls. The results were studied by using linkage, transmission disequilibrium, association and homozygosity analyses. Linkage analyses remained negative, presumably because of our low power for linkage study. However, all the other analyses yielded evidence that the IL9R gene region may have a role in the development of asthma. The sDF2*10 allele was more frequently transmitted than untransmitted to asthmatic offspring (34 vs 16, P 2 ≤ 0.01), and it was found homozygotic among asthma patients more often than expected (P simul2 = 0.009). Also, a specific X chromosomal haplotype, sDF2*10-sDF1*6 associated with asthma (40 vs 7, P 2 < 0.005, P simul1 = 0.04).
Introduction
The interleukin 9 receptor (IL9R) was the first gene to be identified in the pseudoautosomal region (320 kb) of the Xq and Yq chromosomes. The genes in the pseudoautosomal region escape X inactivation and are expressed by both X and Y chromosomes. 1 Four pseudogenes of the IL9R have been located on chromosomes 9q, 10p, 16p and 18p without any functional activity. 2 The IL9R (17 kb, 11 exons) encodes a ligand specific alpha chain (522 amino acids and 64 kDa) for the heterodimeric receptor (α and γ subunits). The receptor is expressed by a variety of haematopoietic cells such as T cells, mast cells, and macrophages. Other interleukin receptors such as IL2, IL4, IL7, and IL15 share the γ chain of the receptor 3 which might explain partially overlapping functions of these interleukins. 4 The gene for IL9 is located on chromosome 5q31-q33 together with an interleukin gene cluster (IL3, IL4, IL5, IL13,
GM-CSF).
Quantitative traits (IgE and bronchial hyperreactivity) associated with asthma have been reported to show linkage to this region. 5, 6 However, linkage to the 5q region has not been confirmed in all populations studied, 7, 8 suggesting population heterogeneity in the molecular genetic background of the traits. IL9 has many biological effects and some of them synergise with IL4 in IgE production. In addition, IL9 induces growth and maturation of mast cells. The IL9 gene has also been linked to bronchial hyper-reactivity in mice, and a reduced expression of IL9 was shown in lung tissue of a hyporesponsive mouse strain, 9 while an IL9 transgenic mouse has elevated serum total IgE level, bronchial hyper-responsiveness and eosinophilia of the airways in response to an antigen challenge. 10 In human, linkage studies have not implicated any gene in 5q, although Doull et al have reported some evidence of an association of the IL9 gene to high serum total IgE level. 11 Among the Finns, a single nucleotide polymorphism in the IL9 gene was found (T113M), but there was no association with high serum total IgE level or asthma.
Increased evidence of the role of IL9 in atopic disorders and having found no association between asthma or high IgE and the interleukin gene cluster in 5q among the Finns, raised the question of other molecules in the IL9 pathway. Polymorphism in the IL4RA gene has been reported to associate with atopy. 12 In the present study, we have analysed two polymorphic markers close to the IL9R gene with regard to asthma and IgE level with different analytical approaches.
Material and methods

Subjects
The study sample consists of 202 nuclear families with 657 study individuals recruited in the Kainuu province of Finland. The inclusion criteria for probands were: selfreported asthma diagnosed by a physician, nuclear family willing to participate, and parents or grandparents born in Kainuu. Our procedure for verification of the diagnosis have been reported in detail. 13 Both the probands and their family members gave written informed consent. Blood samples were collected both for the DNA analysis and for measuring total serum IgE (Diagnostics CAP FEIA, Kabi Pharmacia, Sweden). The ethical committees of the Department of Medical Genetics, University of Helsinki and the Kainuu Central Hospital have approved the study.
Markers and genotyping
DNA was extracted from blood leukocytes by a standard nonenzymatic method. The polymorphic markers sDF1 (DXYS154) (heterozygosity 0.73) and sDF2 (DXS1108) (heterozygosity 0.70) were typed by using published primer sequences. 14 Physical locations of the markers at the boundary of X specific and XY homology regions, not more than 100 kb apart, have previously been established. 15 The IL9R gene is located distal to the markers, close to the telomere (20-30 kb). 2 The PCR assays contained 50 ng of genomic DNA, 0.4 mM of primer mix, 0.3 U of DNA polymerase (Dynazyme, Finnzymes, Finland) and 0.2 mM of each dNTP in a total volume of 20 µl. The PCR conditions were 3 min at 93°C, followed by 30 cycles each of 15-30 s at 93°C, 15-30 s at 50-59°C, 15-30 s at 72°C and final 8 min at 72°C. The samples were electrophoresed on polyacrylamide gels and alleles were visualised by silver staining.
Statistical analyses and power estimations
Single-point non-parametric linkage analysis and transmission disequilibrium test (TDT) were done for both phenotypes, asthma and high serum IgE level, using the computer package GENEHUNTER. 16 In allele and haplotype association studies, a chromosome was marked as 'trait-associated' if it occurred in any affected family member and as 'control' if it occurred only in unaffected family members. 17 Every chromosome in each family was counted only once. The haplotypes were constructed by hand. The allele and haplotype associations were initially analysed with chi-square test (P 2 ). Since the P 2 test was performed multiple times, a permutation test (P simul1 ) was used to estimate the overall significance: 7 the haplotypes were fixed, while the phenotypes of the chromosomes were randomised. The proportion of 1000 such iterations where a stronger association was found than in actual data showed the simulated P simul1 value of the observation. Comparison was done by using P 2 values of the most extreme association in simulated and actual data. The simulations for homozygosity testing (P simul2 ) of the sDF2 alleles were carried out with females only. All unrelated affected females were considered and their observed alleles were used for simulations. Then, in each of 100 000 iterations, random pairs of these alleles were formed, and the number of simulated homozygous chromosome pairs was counted. The iterations provided a distribution for the number of expected homozygotes under the null hypothesis of no excess homozygosity, treating the number of alleles fixed. Finally, the observed number of homozygotes was compared with this distribution to obtain the P simul2 value.
We performed additional simulations (Simul3) also to assess the power of the sample to detect the presence of an ancestral chromosome carrying susceptibility to a trait. 7 A two-locus haplotype was chosen be present at frequency F (5%, 10%, 15% and 20%) among the affected chromosomes of the data set; 10 000 iterations were done for each F and the power to detect association was measured by the fraction of the replicates in which the haplotype showed P 2 = 0.05.
Results
Non-parametric single-point linkage study
Linkage was studied in 80 sib pairs and 62 cousin pairs for asthma and for high serum total IgE level (84 families). Both phenotypes were analysed as qualitative traits (asthmatic vs non-asthmatic and serum IgE > 100 kU/L vs serum IgE ≤ 100 kU/L). 6, 18 Non-parametric linkage score (NPL) remained negative for both markers and for both phenotypes with an information content of 34-46%, but did not allow exclusion.
Transmission disequilibrium test
TDT was analysed first in all the families where the child was affected and both parents had heterozygous genotypes (Table 1 ). In men the genotype for sDF2 was marked as Y (for Y chromosome) and the hemizygous allele (for X chromosome). The allele sDF2*10 was transmitted to 34 and untransmitted to 16 asthmatic offspring (P 2 ≤ 0.01) (Table 1) . When 2-marker haplotypes were analysed the excess of sDF2*10 originated mainly from two parental X chromosomes: sDF2*10-sDF1*6 (11 transmitted vs 3 chromosomes untransmitted, P 2 = 0.03) and sDF2*10-sDF1*1 (5 transmitted vs 0 chromosomes untransmitted, P 2 = 0.03).
IL9R region in asthma P Kauppi et al y TDT was then analysed separately for paternal and maternal transmission to sons and daughters. As expected, the allele spectrum of the pseudoautosomal marker (sDF1) in Y chromosomes was narrower than in X chromosomes, reflecting a founder effect. 19 The analysis also showed female overrepresentation among the patients (67%). These potential confounding factors are avoided when solely maternal transmission to affected daughters is considered (Table 1) . In this test, the haplotype sDF2*10-sDF1*6 was transmitted 5 more frequently to affected daughters than untransmitted (0), (P 2 = 0.03). For high serum IgE, the TDT results were not significant.
Association study
The allele sDF2*10 in X chromosomes was found more frequently in asthma than in control chromosomes (28% vs 20%, P 2 = 0.05) ( Table 2 ). To correct the result for multiple testing, 1000 permutations were done (P simul1 , see methods).
In 176 such permutations for the asthma phenotype, the most extreme allele association found in simulated data was stronger than in actual data (P simul1 = 0.18). The allele frequencies of the marker sDF1 were equally distributed in affected and control chromosomes. Haplotype association analysis was performed on X chromosomes. For asthma, the haplotype sDF2*10-sDF1*6 was found more frequently in affected chromosomes than in control chromosomes (40 affected vs 7 control chromosomes (P 2 < 0.005) ( Table 3 ). In the permutation test, only 40 out of 1000 iterations provided a haplotype association more extreme than in actual data (P simul1 = 0.04). Analysed separately for male and female X chromosomes, the association was significant for females (34 affected haplotypes and 6 controls) by a P 2 test (P < 0.05). For high IgE level, no allele or haplotype associations were found (Table 2) . By power simulations (Simul3), our power to show haplotype association for high total serum IgE level was 99-93%, if the frequency of a susceptibility haplotype among affected chromosomes (F) is between 0.15 and 0.20. When F = 0.10 or F = 0.05 the corresponding power to detect the association decreases (67% and 18%, respectively). Power to detect a haplotype association for the asthma phenotype was similar: 97% (F = 0.20), 81% (F = 0.15), 49% (F = 0.10), and 6% (F = 0.05).
Homozygosity testing
If a marker allele is associated with a disease gene, homozygosity for the allele should associate with the disease even more strongly. When testing this hypothesis with a randomization test (P simul2 ), an excess of homozygosity was found for the sDF2*10 allele and asthma phenotype (Table 4) . Among the asthma patients, 13 sDF2*10 homozygous individuals were observed, whereas the average expected from the simulation was 7.7 (P simul2 = 0.009). For the controls, the number of homozygous individuals was only 3. The overall observed homozygosity for both markers did not differ from the expected, confirming that the study population is in Hardy-Weinberg equilibrium (HWE) ( Table 2) .
Discussion
Recent studies in human and in mice have suggested IL9-mediated effects to be relevant for the development of atopic disorders. To study the counterpart of the ligand, the IL9R gene, we used two polymorphic markers not more than 400 kb centromeric of the IL9R gene instead of a polymorphic repeat in the coding region of the IL9R gene, since IL9R pseudogenes may affect the interpretation of the intragenic polymorphism. 1 Among the Kainuu population, linkage disequilibrium has previously been shown to extend regions much longer than the region studied here. 20 So, we have no reason to believe that the markers would not be in association with possible susceptibility alleles of the IL9R gene.
Holroyd et al have previously found linkage between asthma and this same PAR region with the best NPL score for the marker DXYS154 (sDF1). 21 In our study, association, transmission disequilibrium and homozygosity testing yielded evidence that the IL9R region may have biological significance for the development of asthma. These methods can be more powerful than linkage when multifactorial diseases are studied. 22 Having a young founder population, our sample was designed to have high power for haplotype association if a susceptibility allele is present in at least 15% of the affected chromosomes, whereas our power for genetic linkage study was much lower. Both TDT and haplotype association recognised the same haplotype (sDF2*10-sDF1*6) which was 2.1 times more frequent among haplotype positive affected females than haplotype positive unaffected females. Thus, we propose that sDF2*10-sDF1*6 is a marker of an ancestral chromosome carrying a functional variant of the IL9R gene, although the effect of the gene on the asthma phenotype seems relatively minor at population level. The most important confounding factor which could mislead our conclusions is population admixture. However, we could exclude close relationships between the families and verify the origin of the families by genealogical studies. 7 In addition, no deviation from HWE was detected in this chromosomal region (Table 2 ) or other regions studied previously. 7 The biological significance of a weak association is difficult to interpret especially in complex disorders. In many cases, the reported association has not been found in any other population and the differences between the results have been explained by genetic heterogeneity between the populations. Supporting a role for IL9R, a splice variant in the coding region of the IL9R gene has been reported to alter the binding of IL9 23 which demonstrates the importance of a functional receptor in IL9 signaling. This finding together with the reported positive linkage between asthma and the Xq/Yq pseudoautosomal region 21 is supported by our results of the same region. All this speaks for the relative importance of the 
